Care as usual
PreclinicalSmall molecule
Care as usual is one of 38 small molecule programs targeting Migraine. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
37
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
105 competitors in Migraine
#DrugCompanyPhaseTrials
1Avicel
SSanthera Pharmaceuticals
Phase 3
Magnesium
SSpherium Biomed
Phase 3
Elismetrep
KKallyope Inc.
Phase 3
Flunarizine
AAspartes Pharmaceuticals, Inc.
Phase 3
BAT7104
TevaPhase 3
Bayer Aspirin
BayerPreclinical
Cervidil
PfizerPreclinical
Cymbalta
Jazz PharmaceuticalsPreclinical
Adempas
BayerPreclinical
Nitrostat
VViatris Specialty LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Migraine1 trial
Tertiary Care With or Without Manual Therapy for Chronic Migraine
Completed·—·N/A·NCT03395457·67 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Care as usual. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Southern Denmark